Prosthetic
(artificial) heart valve refers to a device implanted in the heart of a patient
suffering from valvular heart disease. A cardiac surgery is performed to
replace the abnormal heart valve with a prosthetic heart valve. Replacement of
a diseased valve with a prosthetic heart valve results in reduction in
morbidity and mortality associated with the cardiac valve disorder. When the
treatment of heart valve disease reaches a stage where it does not provide
relief to the patient, then surgery recommended as the best alternative to
repair or replace the valve. In case of a valve replacement surgery, carbon
based mechanical valves and biological tissue valve are the types of valves
that can be selected based on the condition. Advancements in technology and
increasing prevalence of heart valve diseases are some major factors projected
to drive growth of the prosthetic heart valve market in the near future.
Get Free PDF Research Brochure for
more Professional and Technical Insights : https://www.coherentmarketinsights.com/insight/request-sample/69
Selection of a Heart Valve also depends on the Type of Polymer
On the basis of
product type, the global prosthetic heart valve market can be segmented into
mechanical heart valves, transcatheter heart valves, and tissue heart valves.
Tissue heart valves are harvested from pig heart valves and cow heart sac. The
life of a tissue valve is 10 to 15 years. Tissue heart valves is further
classified into stented tissue valve, stentless tissue valve, tissue-engineered
valves, homograft valves, and heterograft valves. Aortic valves and mechanical
mitral valves are the two types of mechanical heart valves.
Technologies for
prosthetic heart valves include anti-calcification, sutureless valves,
polymers, and carbon-based technologies. The primary cause of failure of
bioprosthetic valves is structural valve deterioration due to tissue
calcification. An anticalcification technology was developed that may
irreversibly choke calcium binding sites in bioprosthetic valves. In February
2016, the U.S. FDA approved a new technology called sutureless aortic valve
replacement that is used for treatment of aortic valve disease. Sutureless
valves are used to treat aortic valve disease and is a relatively less invasive
for patients. The use of polymers to produce leaflet valves, which have same
benefit of bioprosthetic and mechanical valves has been available since
mid-1950s. Much attention has been focused on thermoplastic polyurethanes due
to its various beneficial properties.
Developed Nations Current Hubs, while Low and Middle Income Countries
to emerge as Major Markets
Increasing prevalence
of heart diseases, technological advancements, government funding, robust
healthcare infrastructure, and rise in healthcare expenditure in the U.S. are
major factors projected to propel growth of the prosthetic heart valve market
in this region. According to Centers for Diseases Control and Prevention (CDC)
about 610,000 people die due to heart diseases in U.S. every year. The growth of prosthetic heart valve market
in Asia is expected to be high in the near future due to increasing incidence
of various chronic diseases and improving healthcare infrastructure in this
region. According to a study published in the Lancet—a U.K.-based medical
journal—the number of people affected by high blood pressure has almost doubled
over past 40 years (from 1975 to 2015).
Get Discount Of This Report : https://www.coherentmarketinsights.com/insight/request-discount/69
Growing Aging Population highly susceptible to Heart Diseases to Spur
growth of the prosthetic heart valve market
Advancements in
technology, increasing aging population, and significant rise in prevalence of
heart valve disorder are some factors that are expected to drive growth of the
prosthetic heart valve market in the near future. However, factors such as high
costs of development, stringent government regulations, reimbursement issues,
and lack of trained professionals are inhibiting growth of the prosthetic heart
valve market to certain extent.
Global players involved in the prosthetic heart valve market
The prosthetic
heart valve market is characterized by the presence of major global
players. Some of the prominent names include Boston Scientific Corporation, St.
Jude Medical, Inc., Sorin S.P.A, Abbott Laboratories, Claret Medical, Inc.,
AorTech, Edwards Lifesciences Corporation, Neovasc Inc., and JenaValve
Technology.
Better Patient Outcomes utilizing Prosthetic Heart Valves to Ensure
Sustained Demand
Developed regions such
as North America and Europe are rapidly growing regions in the prosthetic heart
valve market, mainly attributed to robust healthcare infrastructure, increasing
prevalence of valvular heart disease, and favorable reimbursement scenario. The
experience of using an aortic bioprosthetic valve treated with
anticalcification tissue technology demonstrates excellent valve performance,
safety, and durability. Minimally invasive devices for treatment of heart
surgery are the need of the hour to ensure better patient experience. The
sutureless valve technology is less invasive for patients, which is expected to
witness higher adoption in the near future. Transcatheter has given improved
patient survival rate when compared with medical therapy.
ABOUT US
COMPANY OVERVIEW
Coherent
Market Insights is a global market intelligence and consulting organization
focused on assisting our plethora of clients achieve transformational growth by
helping them make critical business decisions. We are headquartered in India,
having office at global financial capital in the U.S. Our client base includes
players from across all business verticals in over 150 countries worldwide. We
are uniquely positioned to help businesses around the globe deliver practical
and lasting results through various recommendations about operational
improvements, technologies, emerging market trends and new working methods. We
offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We
meticulously study emerging trends across various industries at both the global
and regional levels to identify new opportunities for our clientele. Our global
team of over 100 research analysts and freelance consultants provide market
intelligence from the very molecular country level and also provide a global
perspective of the market. Our team is of the most vital cog in our robust
machinery that gives us the ability to deliver independent insight relying on
our cognitive defusion training module.This allows for an objective and
unbiased assessment of the market. We pride ourselves in my constantly striving
to update our extremely in-depth understanding of the market by closely
monitoring and analyzing markets, trends, and emerging best practices, across
allfathomable industries under the sun. This enables us to equip our valued
clientele with key decisive inputs to capitalize on lucrative growth
opportunities in the market and to follow firmly position themselves on a high
growth path in the future.
CONTACT US
CORPORATE OFFICE:
Raj Shah
Coherent
Market Insights
1001 4th Ave,
1001 4th Ave,
# 3200
Seattle, WA
98154
Tel:
+1-206-701-6702
No comments:
Post a Comment